Volume 24, Number 7—July 2018
Research
Global Distribution of Human Protoparvoviruses
Table 1
Characteristics of cohorts used in study of global distribution of human protoparvoviruses*
Cohort | No. persons | Health status | Mean age, y (range) | No. (%) male:female; unknown | Time of sample collection | Other features |
---|---|---|---|---|---|---|
Finland | 324 | Constitutionally healthy | 40.2 (19–79) | 45 (13.9):279 (86.1) | 2009 Oct | Adults: veterinarians |
United States | 84 | Constitutionally healthy | 41.3 (18–72) | 64 (76.2):20 (23.8) | 2009 Apr | Adults: blood donors |
Iraq | 99 | Constitutionally healthy | 39.7 (18–60) | 71 (71.4):28 (28.3) | 2013 Nov–Dec | Adults: medical staff, blood donors, and university students |
Iran | 107 | Constitutionally healthy | 42.2 (18–77) | 50 (46.7):57 (53.3) | 2015–2016 | Adults: blood donors |
Kenya, children | 107 | Febrile at time of sampling (mean temperature 38.6°C, range 37.5°C–40.4°C) | 6.9 (0.5–17.8) | 59 (55.1):43 (40.2); 5 (4.7)† | 2016 Apr–Aug | Children: includes 9 HIV+ (8 receiving HAART) |
Kenya, adults | 119 | Febrile at time of sampling (mean temperature 38.9°C, range 37.5°C–39.8°C) | 43.3 (18.2–88.3) | 42 (35.3):76 (63.9); 1 (0.8)† | 2016 Apr–Nov | Adults: includes 38 HIV+ (35 receiving HAART) |
*HAART, highly active antiretroviral therapy; +, positive.
†Sex was not specified in the questionnaire.
1Current affiliation: Finnish Food Safety Authority Evira, Helsinki, Finland.
2Current affiliation: University of Turku, Turku, Finland.